Triple targeting host–guest drug delivery system based on lactose-modified azocalix[4]arene for tumor ablation

The supramolecular nanoformulation DOX@LacAC4A integrates passive, active and stimuli-responsive targeting capabilities. It can improve drug accumulation at tumor sites and effectively suppress the growth of tumor cells.